The ability of statins to inhibit HMG-CoA reductase is largely independent of the drug's physicochemical ... also known as the cholesterol efflux regulatory protein (CERP). ABCA1 controls the ...
Variables assessed included perceived causes of lipid disorders (heredity, eating and drinking habits, lack of exercise, other medications, and other causes) and events that triggered concerns ...
Hosted on MSN1mon
Promising therapeutic approach for metabolic liver diseases—researchers target enzyme related to fat metabolismA MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver ... inflammation and fibrotic remodeling (connective tissue scarring). The results were published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results